Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001376817 | SCV001573989 | likely pathogenic | Holocarboxylase synthetase deficiency | 2019-09-07 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Loss-of-function variants in HLCS are known to be pathogenic (PMID: 16134170). This variant has not been reported in the literature in individuals with HLCS-related conditions. This variant is not present in population databases (ExAC no frequency). This variant results in the deletion of part of exon 11 (c.1796-56_1814del) of the HLCS gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. |